OBALON THERAPEUTICS INC (OBLN) has 19 open-market insider trades by 15 insiders since 2016. The most active filer is Kim P. Kamdar, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jesse I. Treu | 10% Owner | — | 1 | $6.0M | 2018-08-23 |
| Gilbert H. Kliman | 10% Owner | — | 1 | $4.0M | 2018-08-23 |
| Parters Vii L. P. Domain | 10% Owner | — | 1 | $1.0M | 2019-08-06 |
| Kim P. Kamdar | Dir | — | 3 | $451K | 2019-08-06 |
| William J. Plovanic | CEOPres | — | 3 | $279K | 2019-11-12 |
| InterWest Management Partners X, LLC | 10% Owner | — | 1 | $100K | 2019-08-06 |
| Andrew P. Rasdal | Chairman | — | 1 | $50K | 2019-08-06 |
| Sharon Stevenson | Dir | — | 1 | $30K | 2019-08-06 |
| Lesley H. Howe | Dir | — | 1 | $25K | 2019-08-06 |
| Robert J. MacDonald | Chief Retail Officer | — | 1 | $20K | 2019-08-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William J. Plovanic | CEO & President | Buy | $108K | 2019-11-12 |
| Robert J. MacDonald | Chief Retail Officer | Buy | $20K | 2019-08-06 |
| Andrew P. Rasdal | Chairman | Buy | $50K | 2019-08-06 |
| InterWest Management Partners X, LLC | 10% Owner | Buy | $100K | 2019-08-06 |
| Amy VandenBerg | Chief Clinical & Reg Officer | Buy | $10K | 2019-08-06 |
| Sharon Stevenson | Director | Buy | $30K |
Companies that share insiders with OBLN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-08-06 |
| Parters Vii L. P. Domain | 10% Owner | Buy | $1.0M | 2019-08-06 |
| Lesley H. Howe | Director | Buy | $25K | 2019-08-06 |
| Jesse I. Treu | 10% Owner | Buy | $6.0M | 2018-08-23 |
| Gilbert H. Kliman | 10% Owner | Buy | $4.0M | 2018-08-23 |
| Kim P. Kamdar | Director | Buy | $200K | 2018-08-23 |
| Neil Drake | VP Research and Development | Buy | $20K | 2018-03-15 |
| William J. Plovanic | CFO | Buy | $121K | 2018-03-13 |
| Matthew Norwood | VP of Sales | Buy | $15K | 2016-10-12 |
| Kim P. Kamdar | Director | Buy | $201K | 2016-10-12 |